gastric cancer Archives

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set goals, according to a NASDAQ filing.

Merck’s Keytruda experimental gastric cancer drug flops in one of set goals

HQ Team June 20, 2023: Merck Group’s investigational drug Keytruda, to treat gastric cancer, has failed to meet one of its two set.

by HealthQuill
June 20, 2023
0 Comments

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.

Drugs Pharma

Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.

by HealthQuill
February 23, 2023
3 Comments